Repligen
RGEN
#1832
Rank
NZ$19.94 B
Marketcap
NZ$314.14
Share price
-6.20%
Change (1 day)
20.67%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$1.48 Billion

According to Repligen 's latest financial reports the company's total liabilities are NZ$1.48 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$1.45 B-4.14%
2024-12-31NZ$1.51 B10.92%
2023-12-31NZ$1.36 B40.08%
2022-12-31NZ$0.97 B9.81%
2021-12-31NZ$0.89 B71.93%
2020-12-31NZ$0.51 B2.5%
2019-12-31NZ$0.50 B113.12%
2018-12-31NZ$0.23 B10.81%
2017-12-31NZ$0.21 B23.37%
2016-12-31NZ$0.17 B405.4%
2015-12-31NZ$34.31 M62.37%
2014-12-31NZ$21.13 M17.69%
2013-12-31NZ$17.95 M14.66%
2012-12-31NZ$15.66 M
2011-03-31NZ$6.84 M-8.58%
2010-03-31NZ$7.48 M-8.33%
2009-03-31NZ$8.16 M38.75%
2008-03-31NZ$5.88 M19.08%
2007-03-31NZ$4.94 M-5.5%
2006-03-31NZ$5.23 M12.18%
2005-03-31NZ$4.66 M27.01%
2004-03-31NZ$3.67 M-9.38%
2003-03-31NZ$4.05 M-33.04%
2002-03-31NZ$6.05 M91.2%
2001-03-31NZ$3.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$205.30 B 13,696.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$107.17 B 7,102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$194.94 B 13,000.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$115.96 B 7,692.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.14 B-90.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.03 B 36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$2.95 B 98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.84 B-42.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$9.59 B 544.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$8.24 B 454.03%๐Ÿ‡บ๐Ÿ‡ธ USA